Symbicort Aerosol
Product Images NDC 85766-184

Product Visual Gallery

This gallery contains 17 technical images submitted to the FDA as part of the official labeling for Symbicort (NDC 85766-184). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sportpharm Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (Figure1bodytext)

Line graph showing percent change from baseline in predicted FEV1 over 12 weeks of treatment for multiple groups including SYMBICORT 160/4.5 mcg, budesonide 160 mcg, formoterol 4.5 mcg, budesonide plus formoterol, and placebo. The x-axis represents weeks of treatment, and the y-axis shows percent change in predicted FEV1.*

FDA Label Image

Figure 2 (Figure2bodytext)

A line graph depicting the percent change from baseline in predose FEV1 over 12 weeks of treatment. The graph compares four groups: SYMBICORT 80/4.5 mcg (two inhalations twice daily), Budesonide 80 mcg (two inhalations twice daily), Formoterol 4.5 mcg (two inhalations twice daily), and a placebo. The vertical axis shows percent change, while the horizontal axis represents time in weeks. Symbol legend identifies each treatment group.*

FDA Label Image

Figure 3 (Figure3bodytext)

Line graph showing the percent change from baseline in FEV1 over 12 hours for various inhalation treatments including SYMBICORT 160/4.5 mcg, Budesonide 160 mcg, Formoterol 4.5 mcg, and a combination of Budesonide 160 mcg with Formoterol 4.5 mcg, each administered as two inhalations twice daily.*

FDA Label Image

Figure 4 (Figure4bodytext)

A line graph depicting percent change from baseline in FEV1 over 12 hours for different treatments, including SYMBICORT 160/4.5 mcg (two inhalations twice daily), budesonide 160 mcg (two inhalations daily), formoterol 4.5 mcg (two inhalations twice daily), a final visit combination of budesonide 160 mcg plus formoterol 4.5 mcg (two inhalations twice daily), and placebo. The graph shows time in hours on the x-axis and percent change in FEV1 on the y-axis, illustrating comparative bronchodilator effects.*

FDA Label Image

Figure 5 (Figure5bodytext)

A line graph comparing the change from baseline in 1-hour post-dose FEV1 (L) over 12 weeks between SYMBICORT 80/4.5 mcg and Budesonide 80 mcg, both administered as two inhalations twice daily. The graph plots mean values for each treatment group at multiple time points, showing higher lung function improvement with SYMBICORT.*

FDA Label Image

Figure 6 (Figure6bodytext)

A line graph showing percent change from baseline in pre-dose FEV1 over a 6-month period during treatment. The x-axis represents time in months (0 to 6), and the y-axis shows percent change from -5 to 15. Multiple lines represent different treatment groups including Symbicort MDI 160/4.5 mcg, budesonide 160 mcg, formoterol 4.5 mcg, a combination of budesonide 160 mcg and formoterol 4.5 mcg, and placebo. Below the graph is a table with sample sizes for each group at multiple time points. The chart illustrates lung function changes with different inhalation treatments administered twice daily.*

FDA Label Image

Figure 7 (Figure7bodytext)

Line graph depicting percent change from baseline in 1-hour post-dose FEV1 across six months and end of treatment for SYMBICORT MDI 160/4.5 mcg, budesonide 160 mcg, formoterol 4.5 mcg, their combination, and placebo. The graph shows FEV1 improvements for all active treatments compared to placebo over time.*

FDA Label Image

Budesonide Structural Formula (Image 01)

Chemical structure diagram showing the molecular composition of the active ingredients in SYMBICORT: Budesonide and Formoterol Fumarate Dihydrate.*

FDA Label Image

Structural Fumarate (Image 02)

Chemical structure of Budesonide and Formoterol Fumarate Dihydrate, the active ingredients in SYMBICORT. The diagram shows molecular structures including two units of the main components and associated fumarate and water molecules.*

FDA Label Image

Figure 1 (Image 03)

An instructional diagram of the SYMBICORT aerosol inhaler showing labeled parts including the counter, canister inside, inhaler body, mouthpiece, strap, and mouthpiece cover.*

FDA Label Image

Figure 2 (Image 04)

An instructional illustration demonstrating how to remove the cap from a Symbicort aerosol inhaler by pressing the sides of the cap and pulling it off, with arrows indicating the direction of force and removal.*

FDA Label Image

Figure 3 (Image 05)

An instructional illustration showing a hand holding a red aerosol inhaler with the cap removed. The inhaler is being activated, releasing a spray from the mouthpiece. The cap is shown below the inhaler, detached. This diagram depicts how to properly hold and activate the inhaler for administration.*

FDA Label Image

Figure 4 (Image 06)

Instructional illustration showing hands using a red and gray inhaler device dispensing aerosol medication onto the skin of a hand or wrist. The image demonstrates how to hold the inhaler and release the spray. No text or dosage details visible other than 'Figure 4' label.*

FDA Label Image

Figure 5 (Image 07)

An illustration showing a person using a Symbicort aerosol inhaler, demonstrating proper inhalation technique. The image emphasizes correct placement of the mouth on the inhaler mouthpiece with the cap detached, supporting respiratory (inhalation) drug delivery.*

FDA Label Image

Counter (arrow pointing to 80)

An instructional dial indicator illustration showing a circular gauge with numbers from 0 to 120 arranged around the edge. The dial has a pointer set near 75 and shaded segments highlighting ranges approximately between 5-25 and 70-80. The image likely represents dose counter settings or usage guidance for the SYMBICORT aerosol inhaler.*

FDA Label Image

Counter (arrow pointing to 15)

An illustrated dial or gauge with numeric markings from 0 to 120, featuring a pointer set near 25. The dial includes shaded segments between 0 and 30, and zero, likely indicating a measurement scale or dose counter.*

FDA Label Image

1 (Label)

Label for Symbicort 80/4.5 inhalation aerosol by Sportpharm LLC. The label includes NDC 85766-184-28 and package quantity of 6.9 inhalation canisters. It states the product is relabeled for Sportpharm and manufactured for AstraZeneca Pharmaceuticals LP. Additional details include batch, lot, expiration, drug status RX, and storage instructions.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.